Dukes Iain D.
Insider CIK 1681955 · TRAW Executive Chairman, Director · LBIO Director · THRX Chairman, Director · IKNA Director · NONE CEO and Chairman, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRAW Traws Pharma, Inc. | A Award deriv | 2026-07-09 | 2026-07-14 | 274,000 | — | $0 | 274,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2026-06-16 | 2026-06-18 | 180,632 | — | $0 | 180,632 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award deriv | 2026-03-08 | 2026-03-10 | 231,336 | — | $0 | 231,336 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award deriv | 2025-12-12 | 2025-12-16 | 147,771 | — | $0 | 147,771 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award | 2025-12-12 | 2025-12-16 | 36,943 | — | $0 | 171,130 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award deriv | 2025-10-12 | 2025-10-15 | 64,839 | — | $0 | 64,839 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2025-06-13 | 2025-06-17 | 135,092 | — | $0 | 135,092 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award deriv | 2024-11-01 | 2024-11-05 | 2,096,667 | — | $0 | 2,096,667 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2024-06-11 | 2024-06-13 | 98,607 | — | $0 | 98,607 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2024-06-07 | 2024-06-10 | 17,520 | — | $0 | 17,520 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award | 2024-04-01 | 2024-08-07 | 67,500 | — | $0 | 134,187 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award deriv | 2024-04-01 | 2024-04-03 | 3,802,890 | — | $0 | 3,802,890 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award deriv | 2024-04-01 | 2024-04-03 | 4,801 | — | $0 | 4,801 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award deriv | 2024-04-01 | 2024-04-03 | 195 | — | $0 | 195 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award | 2024-04-01 | 2024-04-03 | 66,687 | — | $0 | 66,687 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award | 2024-04-01 | 2024-04-03 | 67,550 | — | $0 | 134,187 | SEC↗ |
| TRAW Traws Pharma, Inc. | A Award | 2024-04-01 | 2024-04-03 | 1,645,100 | — | $0 | 1,645,100 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2024-03-01 | 2024-03-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | P Buy | 2024-02-20 | 2024-02-20 | 32,000 | $9.15 | $292.8K | 54,000 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | D To issuer deriv | 2024-02-14 | 2024-02-14 | 3,250 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | D To issuer deriv | 2024-02-14 | 2024-02-14 | 344,344 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | D To issuer deriv | 2024-02-14 | 2024-02-14 | 61,549 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | D To issuer deriv | 2024-02-14 | 2024-02-14 | 36,066 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | U Tender | 2024-02-14 | 2024-02-14 | 388,324 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-13 | 3,250 | — | $0 | 3,250 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-13 | 19,500 | — | $0 | 19,500 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2023-06-09 | 2023-06-13 | 17,520 | — | $0 | 17,520 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2023-06-06 | 2023-06-08 | 103,911 | — | $0 | 103,911 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | P Buy | 2022-11-23 | 2022-11-28 | 10,000 | $6.10 | $61.0K | 22,000 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2022-06-10 | 2022-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2022-06-10 | 2022-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2022-06-10 | 2022-06-14 | 102,409 | — | $0 | 102,409 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 13,419 | — | $0 | 13,419 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2021-12-21 | 2021-12-23 | 23,419 | — | $0 | 23,419 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2021-10-06 | 2021-10-08 | 22,678 | — | $0 | 22,678 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2021-06-29 | 2021-07-01 | 70,000 | — | $0 | 70,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2020-06-08 | 2020-06-10 | 70,000 | — | $0 | 70,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2019-06-10 | 2019-06-11 | 70,000 | — | $0 | 70,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | P Buy | 2018-12-18 | 2018-12-20 | 12,000 | $8.65 | $103.8K | 12,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2018-07-17 | 2018-07-19 | 70,000 | — | $0 | 70,000 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2017-09-08 | 2017-09-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2017-06-01 | 2017-06-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2016-08-16 | 2016-08-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LBIO Lion Biotechnologies, Inc. | A Award deriv | 2016-08-16 | 2016-08-19 | 70,000 | — | $0 | 70,000 | SEC↗ |